Answer to challenging issues in the management of Wilson's disease - 07/02/19
Doi : 10.1016/j.clinre.2018.07.006
Aurélia Poujois a, b, ⁎ 
, France Woimant a, b
, France Woimant a, b a Neurology department, AP–HP, Lariboisière university hospital, 75010 Paris, France
b National reference centre for Wilson's disease, AP–HP, Lariboisière university hospital, 75010 Paris, France
⁎Corresponding author at: National reference centre for Wilson's disease and neurology department, AP–HP, Lariboisière university hospital, 2, rue Ambroise-Paré, 75010 Paris, France.National reference centre for Wilson's disease and neurology departmentAP–HPLariboisière university hospital2, rue Ambroise-ParéParis75010France
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2018
Pubblicato da Elsevier Masson SAS.
Vol 43 - N° 1
P. e7-e8 - Febbraio 2019 Ritorno al numero
Articolo precedente
- The silent course of liver steatosis and fibrosis in an adult patient with Cholesteryl Ester Storage Disease
- Graciela Elia Castro Narro, Alejandra Consuelo Sánchez, Abel Salazar Martínez, Armando Gamboa Domínguez, Héctor Adrián Díaz Hernández, Mario René Pineda de Paz, Rodrigo Joanico Aguilar, Davinia Suárez Flores
- Erratum to “Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature” [Clin. Res. Hepatol. Gastroenterol. 42 (2018) 604–609]
- A. Zullo, R. Manta, V. De Francesco, G. Fiorini, E. Lahner, D. Vaira, B. Annibale
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?